2021 Conference

Abstract:Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for medication resistant depression (Boes et al., 2018; Trapp et al., 2020). Numerous studies have investigated the neurophysiological, neuroanatomical and functional connectivity effects relative to rTMS (Bailey et al., 2019; Ge, Downar, Blumberger, Daskalakis, & Vila- Rodriguez, 2020; Keuper, Terrighena, Chan, Junghoefer, & Lee, 2018; Noda … Read more

Abstract:This presentation will focus on recent developments in CPT coding and insurance reimbursement for neurofeedback and QEEG. The topics covered will include: history of CPT codes to date, proposed changes to current CPT codes with rationale, modifiers for CPT codes (non-covered service, telehealth, etc) and the importance in using them, an update on insurance reimbursement … Read more

Abstract:Considerable global effort has been directed towards vaccination to control the spread of COVID-19. While there is significant success in these preventative efforts, there is still a need to consider options to improve the outcomes of those who have been infected. This presentation discusses photobiomodulation (PBM) as such an option. PBM is increasingly used by … Read more

Abstract:Over the past 20 years the use of QEEG brain mapping has been used to develop neurofeedback treatment strategies. The typical acquisition of the EEG involves eyes open and closed recordings where the subject is not engaged in any activity. Sixty seconds of artifact free data is selected and quantified into specific frequency bands and … Read more

Abstract:From the earliest days of neurofeedback, clinicians have been using this technology to enhance states of meditation and improve mental health. In general, these early approaches focused on increasing the amplitude of alpha and/or theta. These strategies were used to guide the meditator into deeper states of consciousness, enhance creativity, and reduce anxiety. Eventually, these … Read more

Abstract:Considering that life expectancy has increased over the last few years and that age is the main risk factor for the incidence of neurocognitive disorder (NCD), the characterization of the neurobiological substrates that constitute normal cognitive aging has become increasingly relevant, as well as the underpinnings of pathological cognitive aging. Aging is a multidimensional process, … Read more

Abstract:Neuromodulation applied in neurological and psychiatric disorders is becoming an option for patients suffering from these conditions. Noninvasive brain stimulation (NIBS) development has been steady thanks to the evidence coming from clinical trials, and the technological advances that keep improving its efficacy and safety profile. The use of NIBS has significant advantages, such as the … Read more

Abstract:Introduction: Quantitative electroencephalograph (qEEG) and low-resolution electromagnetic brain tomography (LORETA) methods are undervalued and underused for determining the effects of medications on the brain, especially concerning substance use disorders (Cannon, Lubar & Baldwin, 2008; Sokhadze, Cannon & Trudeau, 2008) and medication assisted therapies (MAT). Debate continues about MAT with drugs such as Suboxone despite positive … Read more

Abstract:Neurophenomenological studies are increasingly exploring the brain mechanisms through which psychedelic substances exert their mind-altering effects. A provocative question is whether such knowledge might be harnessed as a means of self-inducing altered states of consciousness by non-pharmacological means, for example through the combination of meditation practices and EEG neurofeedback. Ross et al., (2013) demonstrated that … Read more

Abstract:In neurotherapy we often look for abnormalities in brain function that are related to our clients’ struggles. Concurrently, there has been a trend in our field for a long time to rely on maps to make assessments; however, it is imperative as practitioners that we learn to look at the EEG to verify the features … Read more